Previous close | 246.80 |
Open | 246.40 |
Bid | 247.00 x 0 |
Ask | 247.40 x 0 |
Day's range | 245.40 - 247.20 |
52-week range | 229.40 - 318.00 |
Volume | |
Avg. volume | 34,084 |
Market cap | 182.069B |
Beta (5Y monthly) | 0.16 |
PE ratio (TTM) | 17.27 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 9.60 (3.89%) |
Ex-dividend date | 14 Mar 2024 |
1y target est | N/A |
Q1 2024 Lineage Cell Therapeutics Inc Earnings Call
Halozyme Therapeutics, Inc. (NASDAQ:HALO) Q1 2024 Earnings Call Transcript May 7, 2024 Halozyme Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Thank you for standing by. My name is [Perla] (ph), and I’ll be your conference operator today. […]
Q1 2024 Halozyme Therapeutics Inc Earnings Call